Angiogenesis and prostate cancer: Identification of a molecular progression switch

Cancer Research

Volumn 61, Issue 6, 2001, Pages 2736-2743

  Huss, Wendy J ^a   Hanrahan, Colleen F ^c   Barrios, Roberto J ^a   Simons, Jonathan W ^d   Greenberg, Norman M ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Emory University School of Medicine ^*

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANIMALS; ANTIGENS, CD31; CELL DIFFERENTIATION; DISEASE PROGRESSION; DNA-BINDING PROTEINS; ENDOTHELIAL GROWTH FACTORS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LYMPHOKINES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0035866779     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Tumor dormancy in vivo by prevention of neovascularization
2. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
3. Angiogenesis and tumor metastasis
4. Vascular endothelial growth factor is a secreted angiogenic mitogen
5. Vascular endothelial growth factor B, a novel growth factor for endothelial cells
6. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
7. Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors
8. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: In situ and in vitro expression of VEGF by human prostate cancer cells
9. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia
10. Angiogenesis and prostate cancer. In vivo and in vitro expression of angiogenesis factors by prostate cancer cells
11. Endothelial cell proliferation activity in benign prostatic hyperplasia and prostate cancer: An in vitro model for assessment
12. Expression of vascular endothelial growth factor and its receptors in the rat ventral prostate and Dunning R3327 PAP adenocarcinoma before and after castration
13. Angiogenesis in two human prostate cancer cell lines with differing metastatic potential when growing as solid tumors in nude mice
14. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors
15. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
16. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
17. Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes
18. Identification of vascular endothelial growth factor (VEGF) receptor-2 (Flk-1) promoter/enhancer sequences sufficient for angioblast and endothelial cell-specific transcription in transgenic mice
19. Fibroblast growth factor-2 (FGF-2) induces vascular endothelial growth factor (VEGF) expression in the endothelial cells of forming capillaries: An autocrine mechanism contributing to angiogenesis
20. Induction of vascular endothelial growth factor by insulin-like growth factor 1 in colorectal carcinoma
21. Androgens induce the expression of vascular endothelial Growth factor in human fetal prostatic fibroblasts
22. Identification of vascular endothelial growth factor receptor-1 tyrosine phosphorylation sites and binding of SH2 domain-containing molecules
23. Different signal transduction properties of KDR and Flt-1. Two receptors for vascular endothelial growth factor
24. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells
25. Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway
26. Prostate cancer in a transgenic mouse
27. A transgenic mouse prostate cancer model
28. Pathologic progression of autochthonous prostate cancer in the TRAMP model
29. Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
30. Amplification of RNA
31. Vascular endothelial growth factor: Regulation by cell differentiation and activated second messenger pathways
32. Characterization of the murine VEGF-related factor gene
33. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development
34. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor
35. Molecular cloning of murine FLT and FLT4
36. NYK/FLK-1: A putative receptor protein tyrosine kinase isolated from E10 embryonic neuroepithelium is expressed in endothelial cells of the developing embryo
37. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms
38. Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription
39. Translation of vascular endothelial growth factor mRNA by internal ribosome entry: Implications for translation under hypoxia
40. Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the noble rat
41. Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells
42. Expression of vascular endothelial growth factor receptors in human prostate cancer